NCT00518934

Brief Summary

The purpose of this study is to analyze the safety and efficiency of therapeutic angiogenesis for patients with limb ischemia by transplantation of human cord blood mononuclear cells.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 19, 2007

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 21, 2007

Completed
Last Updated

August 21, 2007

Status Verified

May 1, 2007

First QC Date

August 19, 2007

Last Update Submit

August 20, 2007

Conditions

Ischemia

Keywords

Safety and efficiency of angiogenesis for patients with limbischemia by transplantation of human cord blood mononuclearcells

Interventions

Study for safety and efficiency of therapeutic angiogenesis for patients with limb ischemia by transplantation of human cord blood mononuclear cellOTHER

Eligibility Criteria

AgeUp to 60 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Without evidence of improvement in response to conventional medical therapy
  • Not candidates for surgical intervention or radiologic intervention

You may not qualify if:

  • Malignant disease
  • More than 60 years old
  • Other significant medical conditions, including diabetes mellitus, hypertension, hyperlipidemia, etc.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Samsung Medical Center, Sungkyunkwan University School of Medicine

Seoul, 135-710, South Korea

RECRUITING

Related Publications (1)

  • Kim DI, Kim MJ, Joh JH, Shin SW, Do YS, Moon JY, Kim NR, Lim JE, Kim AK, Eo HS, Kim BS, Cho SW, Yang SH, Park CJ, Shim JS. Angiogenesis facilitated by autologous whole bone marrow stem cell transplantation for Buerger's disease. Stem Cells. 2006 May;24(5):1194-200. doi: 10.1634/stemcells.2005-0349. Epub 2006 Jan 26.

    PMID: 16439614BACKGROUND

MeSH Terms

Conditions

Ischemia

Interventions

Safety

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Accident PreventionAccidentsPublic HealthEnvironment and Public Health

Study Officials

  • Dong-Ik Kim, Professor

    Professor of division of vascular surgery, Samsung Medical Center, Sungkyunkwan University of School of Medicine

    STUDY DIRECTOR

Central Study Contacts

Dong-Ik Kim, Professor

CONTACT

82-2-3410-3467dikim@skku.edu

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 19, 2007

First Posted

August 21, 2007

Last Updated

August 21, 2007

Record last verified: 2007-05

Locations

KR(1)